BIOA Competitors & Alternatives

Compare BioAge Labs, Inc with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

BIOA

Main Stock
$5.53
Tradestie Score
49
Market Cap
$212.23M
Revenue Growth
0.0%
Analyst Upside
+488.7%

Top Competitors

46 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
CRON Cronos Group Inc. Common Share
$3.45
$1.02B 17.0 47 Compare
ZBIO Zenas BioPharma, Inc. Common Stock
$28.23
$931.48M - 50 Compare
MBX MBX Biosciences, Inc. Common Stock
$50.46
$800.41M - 59 Compare
AQST Aquestive Therapeutics, Inc. Common Stock
$4.13
$711.32M - 62 Compare
ESPR Esperion Therapeutics, Inc.
$3.18
$584.71M - 53 Compare
ETON Eton Pharmaceutcials, Inc. Common Stock
$50.02
$543.32M 126.4 67 Compare
GLUE Monte Rosa Therapeutics, Inc. Common Stock
$11.11
$463.20M - 45 Compare
ALMS Alumis Inc. Common Stock
$6.82
$422.50M - 53 Compare
KYTX Kyverna Therapeutics, Inc. Common Stock
$5.73
$258.18M - 58 Compare
IRWD Ironwood Pharmaceuticals, Inc. - Class A
$3.57
$237.15M 4.6 67 Compare

Data updated: Oct 23, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

46 stocks in this industry